Is US Support for Vaccine Patent Waiver Window Dressing?

theAnalysis.news - A podcast by Paul Jay

Podcast artwork

The U.S. announced its support for patent waivers, but it will be a long, drawn-out process that will make little difference to the catastrophe in India and other poor countries. The U.S. failed to promise to export critical material needed for producing the virus in developing countries. Vijay Prashad and Ricardo Petrella on theAnalysis.news with Paul Jay.

Visit the podcast's native language site